Shell Asset Management CO Xencor Inc Transaction History

Shell Asset Management CO

  • $2.29 Billion
  • Q4 2024

A detailed history of Shell Asset Management CO transactions in Xencor Inc stock. As of the latest transaction made, Shell Asset Management CO holds 5,362 shares of XNCR stock, worth $87,454. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,362
Previous 5,389 0.5%
Holding current value
$87,454
Previous $108,000 13.89%
% of portfolio
0.01%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$19.43 - $26.84 $524 - $724
-27 Reduced 0.5%
5,362 $123,000
Q3 2024

Nov 07, 2024
SELL
$15.7 - $21.65 $1,538 - $2,121
-98 Reduced 1.79%
5,389 $108,000
Q1 2024

Jul 31, 2024
SELL
$18.65 - $26.52 $6,434 - $9,149
-345 Reduced 5.92%
5,487 $104,000
Q1 2024

May 14, 2024
SELL
$18.65 - $26.52 $4,177 - $5,940
-224 Reduced 3.7%
5,832 $129,000
Q4 2023

Feb 14, 2024
SELL
$16.53 - $21.42 $30,068 - $38,962
-1,819 Reduced 23.1%
6,056 $129,000
Q3 2023

Nov 08, 2023
SELL
$20.08 - $25.39 $2,489 - $3,148
-124 Reduced 1.55%
7,875 $159,000
Q2 2023

Jul 28, 2023
SELL
$24.77 - $29.9 $1,139 - $1,375
-46 Reduced 0.57%
7,999 $200,000
Q1 2023

May 15, 2023
SELL
$25.95 - $36.95 $726 - $1,034
-28 Reduced 0.35%
8,045 $224,000
Q4 2022

Feb 07, 2023
SELL
$24.79 - $30.86 $40,630 - $50,579
-1,639 Reduced 16.88%
8,073 $210,000
Q3 2022

Nov 14, 2022
SELL
$24.62 - $32.44 $62,657 - $82,559
-2,545 Reduced 20.76%
9,712 $252,000
Q2 2022

Aug 09, 2022
BUY
$19.74 - $29.01 $414 - $609
21 Added 0.17%
12,257 $335,000
Q1 2022

May 04, 2022
SELL
$26.68 - $41.63 $48,264 - $75,308
-1,809 Reduced 12.88%
12,236 $326,000
Q4 2021

Feb 09, 2022
BUY
$33.67 - $43.44 $2,255 - $2,910
67 Added 0.48%
14,045 $563,000
Q3 2021

Nov 04, 2021
SELL
$30.65 - $35.68 $18,390 - $21,408
-600 Reduced 4.12%
13,978 $457,000
Q2 2021

Aug 12, 2021
BUY
$34.33 - $44.68 $27,120 - $35,297
790 Added 5.73%
14,578 $503,000
Q1 2021

May 10, 2021
BUY
$40.81 - $53.88 $216,578 - $285,941
5,307 Added 62.58%
13,788 $594,000
Q2 2020

Aug 10, 2020
BUY
$27.76 - $33.42 $115,342 - $138,860
4,155 Added 96.05%
8,481 $275,000
Q1 2020

May 11, 2020
SELL
$20.69 - $37.79 $1,365 - $2,494
-66 Reduced 1.5%
4,326 $129,000
Q4 2019

Feb 13, 2020
SELL
$32.75 - $41.43 $4,290 - $5,427
-131 Reduced 2.9%
4,392 $151,000
Q3 2019

Nov 12, 2019
SELL
$33.73 - $46.27 $1,315 - $1,804
-39 Reduced 0.85%
4,523 $153,000
Q2 2019

Aug 12, 2019
SELL
$29.6 - $40.93 $3,078 - $4,256
-104 Reduced 2.23%
4,562 $187,000
Q1 2019

May 09, 2019
BUY
$27.85 - $38.09 $129,948 - $177,727
4,666 New
4,666 $145,000

Others Institutions Holding XNCR

# of Institutions
207
Shares Held
75.6M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $974M
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email